allogeneic plx-pad cells
Cell therapyexperimental
Clinical trial activity
11 trials · 29 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
6
Phase 3
2
Phase 4
0
Earliest trial started Jun 1, 2009 (NCT00919958)
Timeline
Indications
Studied for
- Arthroplasty, Replacement, Hip · Phase 1/Phase 2
- Chronic Limb-Threatening Ischemia · Phase 3
- COVID-19 · Phase 2
- Hip Fractures · Phase 3
- Intermittent Claudication · Phase 2
- Peripheral Arterial Disease · Phase 2
- Peripheral Vascular Diseases · Phase 1
- Pulmonary Arterial Hypertension · Phase 1
- Severe Acute Respiratory Syndrome · Phase 2
- Sprains and Strains · Phase 1/Phase 2
Mechanism of action
- Stem CellTissue restoration
Stem Cell tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 150m plx-pad
- allogeneic plx-pad cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04614025 | Phase 2 | Nov 30, 2020 | Pluristem Ltd. |
| NCT04389450 | Phase 2 | May 31, 2020 | Pluristem Ltd. |
| NCT03451916 | Phase 3 | Jun 30, 2018 | Pluristem Ltd. |
| NCT03006770 | Phase 3 | May 22, 2017 | Pluristem Ltd. |
| NCT01795950 | Phase 1 | Apr 1, 2013 | United Therapeutics, University of Queensland |
| NCT01525667 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2012 | Pluristem Ltd. |
| NCT01679990 | Phase 2 | Oct 1, 2012 | Aiyan Diabetes Center, Evans, GA, Ajou University, Cha Medical University, Clinical Trials of Texas, Inc, DMI Research, Pinellas Park FL, Dong-A University, Duke University, Florida Research Network, Franziskus Hospital, Berlin, Hallym University, Icahn School of Medicine at Mount Sinai, Ilsan Hospital, Kangbuk Samsung Hospital, Korea University, Omega Medical Research, Pluristem Ltd., Pusan National University, Tampa Bay Medical Research, Tel Aviv University, Turkey Creek Medical Center, Knoxville, University of Hamburg, University of Heidelberg, University of Kentucky, University of Minnesota, University of Pennsylvania |
| NCT00951210 | Phase 1 | Aug 1, 2009 | Pluristem Ltd. |
| NCT00919958 | Phase 1 | Jun 1, 2009 | Humboldt University, Pluristem Ltd. |
| NCT03746899 | N/A | — | WideTrial, Inc. |
| NCT03886506 | N/A | — | Pluristem Ltd. |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (29)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pluristem Ltd. | For profit | 9 | 9 | 4 | 2009 |
| Aiyan Diabetes Center, Evans, GA | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Ajou University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Cha Medical University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Clinical Trials of Texas, Inc | For profit | 1 | 0 | 1 | 2012 |
| DMI Research, Pinellas Park FL | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Dong-A University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Duke University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Florida Research Network | For profit | 1 | 0 | 1 | 2012 |
| Franziskus Hospital, Berlin | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Hallym University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Humboldt University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Ilsan Hospital | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Kangbuk Samsung Hospital | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Korea University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Omega Medical Research | For profit | 1 | 0 | 1 | 2012 |
| Pusan National University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Tampa Bay Medical Research | For profit | 1 | 0 | 1 | 2012 |
| Tel Aviv University | Academic/Hospital | 1 | 0 | 1 | 2012 |
29 organizations
Page 1 / 2